Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
Open | $0.58 |
Close | - |
Volume / Avg. | 33.42K / 227.10K |
Day Range | $0.56 - $0.60 |
52 Wk Range | 0.50 - 1.98 |
Market Cap | $2.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.28% |
Days to Cover | 1.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIX) through any online brokerage.
Other companies in Protagenic Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Protagenic Therapeutics has a consensus price target of $4.00.
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $0.56 last updated September 23, 2024 at 9:23 AM EDT.
There are no upcoming dividends for Protagenic Therapeutics.
Protagenic Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Protagenic Therapeutics.
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.